Jeffrey E. Galpin

1.8k total citations
24 papers, 1.2k citations indexed

About

Jeffrey E. Galpin is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Jeffrey E. Galpin has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Virology. Recurrent topics in Jeffrey E. Galpin's work include HIV Research and Treatment (3 papers), Virus-based gene therapy research (3 papers) and Streptococcal Infections and Treatments (3 papers). Jeffrey E. Galpin is often cited by papers focused on HIV Research and Treatment (3 papers), Virus-based gene therapy research (3 papers) and Streptococcal Infections and Treatments (3 papers). Jeffrey E. Galpin collaborates with scholars based in United States, United Kingdom and South Africa. Jeffrey E. Galpin's co-authors include Arnold S. Bayer, Lucien B. Guze, Anthony W. Chow, Michael J. Blumenkrantz, John Z. Montgomerie, Jack W. Coburn, Jerome E. Groopman, Steven A. Miles, William J. Rôbbins and Peter G. E. Kennedy and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Jeffrey E. Galpin

24 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey E. Galpin United States 15 291 271 214 189 153 24 1.2k
P. A. Pizzo United States 24 605 2.1× 758 2.8× 173 0.8× 120 0.6× 150 1.0× 35 2.3k
G. Beaucaire France 22 245 0.8× 855 3.2× 19 0.1× 95 0.5× 114 0.7× 91 1.7k
Hee‐Won Moon South Korea 23 324 1.1× 427 1.6× 139 0.6× 143 0.8× 40 0.3× 109 1.5k
Michael Schwameis Austria 23 320 1.1× 309 1.1× 264 1.2× 191 1.0× 14 0.1× 96 1.6k
Michael R. Weitekamp United States 12 306 1.1× 430 1.6× 45 0.2× 185 1.0× 8 0.1× 20 1.3k
Jaime Guardia Spain 27 301 1.0× 2.2k 8.1× 47 0.2× 45 0.2× 46 0.3× 58 2.9k
Anne F. Eder United States 29 168 0.6× 194 0.7× 741 3.5× 579 3.1× 12 0.1× 77 2.7k
Leon G. Smith United States 16 418 1.4× 455 1.7× 47 0.2× 176 0.9× 24 0.2× 51 1.3k
Hiroki Tsukada Japan 23 308 1.1× 422 1.6× 80 0.4× 46 0.2× 107 0.7× 65 1.4k
Guillermina Barril Spain 22 262 0.9× 740 2.7× 61 0.3× 48 0.3× 42 0.3× 89 1.6k

Countries citing papers authored by Jeffrey E. Galpin

Since Specialization
Citations

This map shows the geographic impact of Jeffrey E. Galpin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey E. Galpin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey E. Galpin more than expected).

Fields of papers citing papers by Jeffrey E. Galpin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey E. Galpin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey E. Galpin. The network helps show where Jeffrey E. Galpin may publish in the future.

Co-authorship network of co-authors of Jeffrey E. Galpin

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey E. Galpin. A scholar is included among the top collaborators of Jeffrey E. Galpin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey E. Galpin. Jeffrey E. Galpin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talal, Andrew H., Marija Zeremski, Rositsa B. Dimova, et al.. (2011). Randomized Trial Comparing Dose Reduction and Growth Factor Supplementation for Management of Hematological Side Effects in HIV/Hepatitis C Virus Patients Receiving Pegylated-Interferon and Ribavirin. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(3). 261–268. 8 indexed citations
2.
Cohen, Cheryl, Alan Karstaedt, John Frean, et al.. (2005). Increased Prevalence of Severe Malaria in HIV-Infected Adults in South Africa. Clinical Infectious Diseases. 41(11). 1631–1637. 141 indexed citations
3.
Schutzbank, Ted E., et al.. (2003). Smallpox: Residual Antibody after Vaccination. Journal of Clinical Microbiology. 41(9). 4068–4070. 23 indexed citations
4.
Duvic, Madeleine, Alvin E. Friedman‐Kien, David J. Looney, et al.. (2000). Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials.. PubMed. 136(12). 1461–9. 46 indexed citations
5.
Duvic, Madeleine, Alvin E. Friedman‐Kien, David J. Looney, et al.. (2000). Topical Treatment of Cutaneous Lesions of Acquired Immunodeficiency Syndrome–Related Kaposi Sarcoma Using Alitretinoin Gel. Archives of Dermatology. 136(12). 1 indexed citations
6.
Skinner, G. R. B., Mary Turyk, Constance A. Benson, et al.. (1997). The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trial. Medical Microbiology and Immunology. 186(1). 31–36. 25 indexed citations
7.
Bahner, Ingrid, Gerhard Bauer, Sarah Wheeler, et al.. (1997). Suitability of Bone Marrow from HIV-1-Infected Donors for Retrovirus-Mediated Gene Transfer. Human Gene Therapy. 8(3). 301–311. 19 indexed citations
8.
Goldstein, Gideon, Marcus A. Conant, Gildon Beall, et al.. (1995). Safety and Efficacy of Thymopentin in Zidovudine (AZT)-Treated Asymptomatic HIV-Infected Subjects with 200–500 CD4 Cells/mm3: A Double-Blind Placebo-Controlled Trial. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 8(3). 279–288. 3 indexed citations
9.
10.
11.
Fischl, Margaret A., Jeffrey E. Galpin, James D. Levine, et al.. (1990). Recombinant Human Erythropoietin for Patients with AIDS Treated with Zidovudine. New England Journal of Medicine. 322(21). 1488–1493. 272 indexed citations
12.
Kay, Marguerite M.B., Jeffrey E. Galpin, & Takashi Makinodan. (1980). Aging, immunity, and arthritic disease. Raven Press eBooks. 1–258. 7 indexed citations
13.
Galpin, Jeffrey E., et al.. (1978). Treatment of Cutaneous Herpesvirus hominis Type 2 Infection with 8-Methoxypsoralen and Long-Wave Ultraviolet Light in Guinea Pigs. The Journal of Infectious Diseases. 137(6). 715–721. 3 indexed citations
14.
Chow, Anthony W., Jeffrey E. Galpin, & L. B. Guze. (1977). Clindamycin for Treatment of Sepsis Caused by Decubitus Ulcers. The Journal of Infectious Diseases. 135(Supplement). S65–S68. 23 indexed citations
15.
Bayer, Arnold S., Michael J. Blumenkrantz, John Z. Montgomerie, et al.. (1976). Candida peritonitis. The American Journal of Medicine. 61(6). 832–840. 90 indexed citations
16.
Bayer, Arnold S., Thomas T. Yoshikawa, Jeffrey E. Galpin, & Lucien B. Guze. (1976). UNUSUAL SYNDROMES OF COCCIDIOIDOMYCOSIS: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS. Medicine. 55(2). 131–152. 55 indexed citations
17.
Bayer, Arnold S., Stephen C. Nelson, Jeffrey E. Galpin, Anthony W. Chow, & Lucien B. Guze. (1975). Necrotizing pneumonia and empyema due to clostridium perfringens. The American Journal of Medicine. 59(6). 851–856. 33 indexed citations
18.
Bayer, Arnold S., R. James Brenner, Jeffrey E. Galpin, & L. B. Guze. (1975). Severe disabling polyarthritis associated with bacterial endocarditis.. PubMed. 123(5). 404–6. 7 indexed citations
19.
Galpin, Jeffrey E., et al.. (1974). "Pseudoanaphylactic" Reactions from Inadvertent Infusion of Procaine Penicillin G. Annals of Internal Medicine. 81(3). 358–359. 27 indexed citations
20.
Galpin, Jeffrey E., et al.. (1971). Ulcerative Colitis in Female Monozygotic Twins and a Female Sibling. Gastroenterology. 61(4). 507–512. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. A. Pizzo Breakdown of academic impact, for papers by G. Beaucaire Breakdown of academic impact, for papers by Hee‐Won Moon Breakdown of academic impact, for papers by Michael Schwameis Breakdown of academic impact, for papers by Michael R. Weitekamp Breakdown of academic impact, for papers by Jaime Guardia Breakdown of academic impact, for papers by Anne F. Eder Breakdown of academic impact, for papers by Leon G. Smith Breakdown of academic impact, for papers by Hiroki Tsukada Breakdown of academic impact, for papers by Guillermina Barril
Rankless by CCL
2026